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1.  IntroductIon
Currently, the entire world is facing the lockdown type 
situation caused by Severe Acute Respiratory Syndrome 
Coronavirus-2 (SARS-CoV-2), identified as the novel 
coronavirus (nCoV, family: Coronoaviridae) responsible for 
causing the Coronavirus Disease in 2019 designated as COVID-
191. The recent outbreak of novel coronavirus (nCoV-2019) or 
SARS-CoV-2 has raised a challenged to design a drug for this 
deadly virus. However, to date, no approved drug is available 
for this pathogenic virus (infectious pathogen transmitted 
through Human to Human). Computational drug discoveries 
against SARS-CoV-2 from natural sources has been suggested 
and tried by many scientist across the globe this year. This 
includes several in silico studies and few wet lab trials2-4. 
This novel coronavirus marked its origin from Wuhan, 
the capital of Central China’s Hubei province. Bats, birds, 
camels, and pangolins are considered as the potential natural 
reservoir of SARS-CoV-2 and the virus was later transmitted 
to humans. The COVID-19 virus is fatal to humans in most 
of the cases and the mortality rate is increasing day by day 
(killed over 45,000 people and infected over 9,00,000)5. 
Symptoms related to COVID-19 includes Sore Throat, Fever, 
Pneumonia, Sneezing, Headache, Cough, Acute Respiratory 
Distress Syndrome, Acute Cardiac Injury, Rhonorrhea, 
Fatigue, Sputum Production, Haemoptysis, Ground Glass 
Opacities, Hypoxemia, Dysponea, RNAaemia, Lymphopenia 
and Diarrhoea6. Every country is devising different strategies 
to minimise the outbreak of SARS-CoV-2 responsible for the 
COVID-19 pandemic7. Several medicines and vaccines are 
under trial to find the possible cure against the SARS-CoV-
28, meanwhile, precautionary measures and social distancing 
have been suggested and the only way to limit the spread of 
coronavirus9-10. 
The genome of SARS-CoV-2 consists of a positive 
single-stranded RNA [(+) ssRNA]. Various proteins present 
in the viral structure are Spike (S) glycoprotein, Nucleocapsid 
(N) phosphoprotein, Membrane (M) glycoprotein and Small 
Envelope (E) glycoprotein11. Teams of doctors and scientists 
are working day and night to find a possible cure to tackle this 
virus. Keeping this in view, here we have presented a study 
which might be helpful for scientists and doctors. One such 
computational molecular docking approach has been taken 
up by us which might be helpful in developing antiviral 
compounds against this deadly virus. 
2.  MaterIal and Methods
Protein and ligand interactions play a crucial role, wherein 
the latter is responsible for limiting/diminishing the activity of 
the former in many human cellular and biological functions. In 
our study, we have taken the assistance of online freely available 
DockThor Portal (www.dockthor.lncc.br) designed for receptor-
ligand docking, developed by Grupo de Modelagem Molecular 
de Sistemas Biológicos (GMMSB) (www.gmmsb.lncc.br) 
situated at  Laboratório Nacional de Computação Científica 
(LNCC) Petrópolis – Brazil, which runs virtual screening 
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Portal is well equipped with software’s like MMFFLigand, 
PdbThorBox, DockThor, and Dtstatistic12. 
For docking, we have considered four SARS-CoV-2 
proteins as receptor molecules and the same were mined from 
the PDB database (www.rcsb.org/) in the .pdb format i.e. (a) 
SARS-CoV-2 nucleocapsid protein N-terminal RNA binding 
domain (6M3M), (b) Nsp9 RNA binding protein of SARS 
CoV-2 (6W4B), (c) The crystal structure of COVID-19 main 
protease in apo form (6M03), (d) Structure of the 2019-nCoV 
HR2 Domain (6LVN). These four SARS-CoV-2 proteins were 
docked separately against five ligand molecules i.e. Piperine 
(Black Pepper: Piper nigrum), Eugenol (Clove: Syzygium 
aromaticum), Alliin (Garlic: Allium sativum), Gingerol (Ginger: 
Zingiber officinale) and Curcumin (Turmeric: Curcuma longa). 
Avoiding the harmful effects of chemical based compounds, 
selection of phytochemicals were made based on a green 
approach. These medicinal plant-based phytochemicals were 
considered and their 3 D structure files were retrieved from the 
PubChem (pubchem.ncbi.nlm.nih.gov/) database in the .sdf 
format, later converted to .pdb format. The retrieved receptors 
and ligand files were uploaded / submitted to the DockThor 
Portal for docking study. Parameters taken up during the 
docking procedure were Number of Evaluations: 1000000, 
Population Size: 750, Initial Seed: -1985, Number of Runs: 24, 
Docking: Soft, Spatial discretisation of the energy grid: 0.25Å, 
Grid points: <1,000,000. Water molecules were excluded from 
the structure and the results were downloaded, analysed and 
viewed on JSmol (View 3D) option provided by the server.
3.  results and dIscussIon
The submitted project on the DockThor Portal employs 
the computational facilities provided by the Brazilian 
SINAPAD (Sistema Nacional de Alto Desempenho) having a 
high-performance platform. upon completion, the DockThor 
Portal generated twenty-four different models for each docking 
experiment (4 x 5 x 24 = 480 in total) between the SARS-
CoV-2 protein receptors and phytochemical ligands and the 
best ones were selected. This virtual screening method initially 
docks and then scores individual ligand molecules. Their Total 
Energy (T. Energy) [Total Energy = Intermolecular ligand-
receptor + Intramolecular ligand energies], Interaction Energy 
(I. Energy), van der Waals energy (vdW), Coulomb energy 
table 1.  docking data generated by dockthor server between various ligands molecules and coronavirus proteins as receptor 
molecules available in the PdB (Protein data Bank) database. 
s. no. ligand Plant t. energy I.energy vdW coul num rotors rMsd score
6M3M
Piperine Pepper 8.352 -23.093 -0.158 -2.935 4 0.000 -8.118
Eugenol Clove 7.558 -20.325 -11.632 -8.693 3 0.000 -7.331
Alliin Garlic -10.510 -25.844 -2.279 -23.565 5 0.000 -6.355
Gingerol Ginger -3.213 -31.300 -18.842 -12.458 10 0.000 -7.897
Curcumin Turmeric 30.841 -34.224 -19.053 -15.171 8 0.000 -8.195
6W4B
Piperine Pepper 29.771 -1.488 -1.194 -0.294 4 0.000 -5.925
Eugenol Clove 26.386 -1.335 -1.265 -0.070 3 0.000 -5.966
Alliin Garlic 12.292 -1.377 -1.129 -0.248 5 0.000 -5.859
Gingerol Ginger 24.488 -1.213 -1.100 -0.113 10 0.000 -5.878
Curcumin Turmeric 59.240 -1.422 -1.338 -0.084 8 0.000 -5.969
6M03
Piperine Pepper 0.686 -30.939 -17.942 -12.997 4 0.000 -8.167
Eugenol Clove 6.843 -23.038 -3.559 -19.479 3 0.000 -6.625
Alliin Garlic -14.407 -29.422 -6.038 -23.384 5 0.000 -6.461
Gingerol Ginger -5.959 -41.082 -11.427 -29.655 10 0.000 -6.957
Curcumin Turmeric 25.169 -43.148 -14.385 -28.763 8 0.000 -7.045
6LVN
Piperine Pepper 31.226 -0.032 -0.001 -0.031 4 0.000 -5.705
Eugenol Clove 27.686 -0.022 -0.001 -0.021 3 0.000 -5.640
Alliin Garlic 13.641 -0.026 -0.001 -0.025 5 0.000 -5.332
Gingerol Ginger 25.801 -0.023 -0.001 -0.022 10 0.000 -5.263
Curcumin Turmeric 60.633 -0.023 -0.001 -0.022 8 0.000 -5.440
T. Energy = Total Energy; I. Energy = Interaction Energy; vdW = van der Waals energy; Coul = Coulomb energy; NumRotors = Number of rotatble chemical bonds; 
RMSD = Root Mean Square Deviation
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(Coul), Number of rotatable chemical bonds (NumRotors) 
and Root Mean Square Deviation (RMSD) values are given 
in Table 1. The best scores are given in the last column of the 
table on which these models were selected. 
In all the screened ligands, a minimum number of 
NumRotors were found in Eugenol ligand and maximum 
in the case of Gingerol. These values give an idea of the 
conformational difference between the alternative ligand 
binding modes. All the suggested ligand molecules showed 
docking with their respective receptor molecules and their 
detailed three-dimensional view can be seen perfectly in 
(Annexure I). SARS-CoV-2 proteins can be visualised in 
their secondary structure and ribbon form, whereas ligands 
molecules are presented in Grey colour at the centre of each 
docking results. Cases of COVID-19 patients are increasing 
across the globe and even diagnosed in those humans which 
had no travel history to China suggesting the seriousness of 
this pandemic and demands for curing at earliest13. In the race 
of various clinical trials on several vaccines that are underway 
and using traditional medicine against the coronavirus, there 
is a great demand to find its cure14, 15. The performed study 
showed the synergistic nature of the compounds within each 
medicinal plant. Combination of the most enriched plants in 
the created network could be chosen for mitigation of SARS-
CoV-2. Further molecular dynamic simulation studies, in vitro 
and in vivo analyses are required to confirm the results of our 
study, however, the insights provided by the present study 
may authenticate valuable investigation and development 
of anti-SARS-CoV-2 compounds having natural origin with 
therapeutic properties.
4.  conclusIon
We have done a green approach based on docking studies 
previously on plant viruses16-17. This time we have applied this 
tactic on animal virus Severe Acute Respiratory Syndrome 
Coronavirus-2 (SARS-CoV-2) which considered humans, 
bats, pangolins as its host. All the ligand molecules used in 
this in silico experiment (dry lab) have strong antioxidant and 
medicinal properties and they can be coupled/conjugated with 
drug molecules in wet lab conditions to develop better antiviral 
compounds. This might be a solution against the pandemic 
caused by the deadly novel coronavirus (COVID-19). This 
manuscript will help scientists and doctors to consider such 
ligands in their future drug development and targeting 
experiments against SARS-CoV-2. 
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figure 1.  structure of the 2019-ncoV 
hr2 domain (6lVn).
figure 2. 6lVn vs Piperine. figure 3. 6lVn vs eugenol.
annexure I
figures 1 to 24: 3 d (three dimensional) ribbon views of the docking results generated by dockthor server between various ligands 
molecules and coronavirus proteins as receptor molecules available in the PdB (Protein data Bank) database. ligands 
molecules are presented in grey colour at the centre of each docking results.
figure 4. 6lVn vs alliin. figure 5. 6lVn vs gingerol. figure 6. 6lVn vs curcumin.
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figure 7. structure of the coVId-19 main protease in apo 
form (6M03). figure 8. 6M03 vs Piperine.
figure 9. 6M03 vs eugenol. figure 10. 6M03 vs alliin.
figure 11. 6M03 vs gingerol. figure 12. 6M03 vs curcumin.
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figure 13. structure of the sars-coV-2 nucleocapsid protein 
n-terminal rna binding domain (6M3M).
figure 16. 6M3M vs alliin.figure 15. 6M3M vs eugenol.
figure 14. 6M3M vs Piperine.
figure 17. 6M3M vs gingerol. figure 18. 6M3M vs curcumin.
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figure 22. 6W4B vs alliin.figure 21. 6W4B vs eugenol.
figure 20. 6W4B vs Piperine.
figure 19. structure of the nsp9 rna binding protein of sars coV-2 
(6W4B).
figure 23. 6W4B vs gingerol. figure 24. 6W4B vs curcumin.
